Evidence map›Paper›PMID 40947457›Full record

ArticleInternational urology and nephrology2026

Can

Fadime Demir, Mustafa Demir, Seyhan Karaçavuş, Muhammet İkbal Yeşilyurt, Mahmut Burak Laçin

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Fadime DemirDepartment of Nuclear Medicine, Kayseri SUAM, Kayseri, Turkey. drfadimedemir@hotmail.com.
Mustafa DemirDepartment of Nephrology, Kayseri SUAM, Kayseri, Turkey.
Seyhan KaraçavuşDepartment of Nuclear Medicine, Kayseri SUAM, Kayseri, Turkey.
Muhammet İkbal YeşilyurtDepartment of Nuclear Medicine, Kayseri SUAM, Kayseri, Turkey.
Mahmut Burak LaçinDepartment of Radiology, Kayseri SUAM, Kayseri, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim is to investigate the correlation between renal maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), molecular kidney volume (MKV), and total kidney uptake (TKU), which are indicators of the PSMA kidney uptake pattern in

methodsThe study included 196 patients with prostate cancer who underwent

resultsWhen comparing eGFR, BUN, and creatinine values with PET/CT renal parameters, a significant correlation was found between eGFR and MKV (r = 0.397), TKU (r = 0.271), and CT-KV (r = 0.216). Similar correlations were also observed for BUN and creatinine. When patients were grouped based on eGFR values, Group 1 (eGFR > 90; normal) included 75 patients, Group 2 (eGFR: 89-60; mild reduction) included 98 patients, and Group 3 (eGFR: 59-30; moderate reduction) included 21 patients. Significant differences were observed between the groups in terms of TKU, MKV, and CT-KV. In post-hoc analyses, the most significant parameter was MKV.

conclusion

Indexed as

Edetic AcidKidneyPositron Emission Tomography Computed TomographyProstatic NeoplasmsRadiopharmaceuticalsAgedAged, 80 and overGallium IsotopesGallium RadioisotopesGlomerular Filtration RateHumansKidney Function TestsMaleMiddle AgedOligopeptidesRetrospective StudiesEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesRadiopharmaceuticals68Ga-PSMA-11eGFRKeywordsMolecular Kidney VolumePET/CTRenal Uptake

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.